Skip to main content
Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
China flag China · Delayed Price · Currency is CNY
8.32
+0.09 (1.09%)
At close: Mar 10, 2026

SHE:002581 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2015
Market Capitalization
5,4897,0209,63210,39114,08512,093
Upgrade
Market Cap Growth
-23.18%-27.12%-7.30%-26.23%16.48%153.18%
Upgrade
Enterprise Value
5,3586,7069,53610,51514,11712,037
Upgrade
Last Close Price
8.3210.6414.6015.7521.3518.33
Upgrade
PE Ratio
----51.98-
Upgrade
PS Ratio
21.3019.4822.4129.1034.9843.68
Upgrade
PB Ratio
2.753.474.434.195.705.52
Upgrade
P/TBV Ratio
3.103.844.914.606.256.13
Upgrade
P/OCF Ratio
-----653.31
Upgrade
EV/Sales Ratio
20.7918.6122.1929.4535.0543.48
Upgrade
EV/FCF Ratio
-17.98-----
Upgrade
Debt / Equity Ratio
0.040.000.010.070.070.08
Upgrade
Net Debt / Equity Ratio
-0.13-0.25-0.06-0.010.00-0.05
Upgrade
Net Debt / EBITDA Ratio
1.4710.131.570.170.070.58
Upgrade
Net Debt / FCF Ratio
0.8532.353.370.220.102.38
Upgrade
Asset Turnover
0.110.160.170.130.160.09
Upgrade
Inventory Turnover
1.521.061.131.061.270.80
Upgrade
Quick Ratio
3.417.893.021.051.833.17
Upgrade
Current Ratio
4.209.043.721.422.203.70
Upgrade
Return on Equity (ROE)
-12.43%-6.81%-13.84%-0.03%11.96%-8.65%
Upgrade
Return on Assets (ROA)
-5.39%-2.50%-3.74%-3.90%-4.90%-5.55%
Upgrade
Return on Invested Capital (ROIC)
-12.04%-5.11%-6.93%0.48%-9.00%-12.24%
Upgrade
Return on Capital Employed (ROCE)
-9.60%-4.30%-7.10%-7.00%-8.20%-11.60%
Upgrade
Earnings Yield
-4.02%-1.96%-3.45%-0.14%1.92%-1.62%
Upgrade
FCF Yield
-5.43%-0.22%-0.42%-0.83%-0.76%-0.41%
Upgrade
Payout Ratio
----2.48%-
Upgrade
Buyback Yield / Dilution
-0.28%-0.01%-0.22%0.21%0.00%-0.02%
Upgrade
Total Shareholder Return
-0.28%-0.01%-0.22%0.21%0.00%-0.02%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.